Prove It: Early Pilots and Validation Studies to demonstrate clinical and operational impact

​Enterprise healthcare customers are demanding that vendors and service organizations come with data - proving that their solutions actually drive clinical and operational outcomes.

What preseed and seed teams get wrong about early pilots and validation studies is that they rarely solve for endpoints that actually prove clinical or operational impact or have any sway with potential enterprise healthcare buyers.

Join MarkOne Health for a panel including enterprise buyers and founders on what to test, how to test, and how to use those outcomes to get traction for your healthcare solutions.

​Evan Huang is CTO of Lightbeam Health. He was previously the cofounder of Caresignal, a national-scale RPM platform which exited to Lightbeam in 2021. At Caresignal, Evan established a 5k patient umbrella IRB under which they ran clinical studies on all of their programs and published many towards establishing both ROI and clinical efficacy for new payer customers.

David Berger MD MHCM is a digital health entrepreneur and advisor Dr. Berger is formerly a surgical oncologist and physician executive. He has been CEO of University Hospital at Downstate and COO of Baylor St. Luke’s Medical Center. He brings a wealth of customer perspective both evaluating and implementing digital health solutions at health system scale.

Ed Jiang is an experienced actuary and currently VP of Medical Economics at CareAbout, a 6k+ provider primary care ACO. He has extensive experience on both the payer and provider side of healthcare economics and leverages that in his advisory and consulting practice, Dr. ROI.

By signing up for this event, you're consenting to event photography and will be added to our monthly mailer of MarkOne and other NYC Healthtech events.